Publication:
Doping and sports endocrinology: anabolic-androgenic steroids

dc.contributor.authorGarcia-Arnes, J. A.
dc.contributor.authorGarcia-Casares, N.
dc.contributor.authoraffiliation[Garcia-Arnes, J. A.] Univ Malaga, Fac Med, Dept Farmacol, Malaga, Spain
dc.contributor.authoraffiliation[Garcia-Casares, N.] Univ Malaga, Fac Med, Dept Med, Malaga, Spain
dc.contributor.authoraffiliation[Garcia-Casares, N.] Univ Malaga, Ctr Invest Med Sanitarias CIMES, Malaga, Spain
dc.contributor.authoraffiliation[Garcia-Casares, N.] Inst Invest Biomed Malaga IBIMA, Malaga, Spain
dc.date.accessioned2023-05-03T15:15:50Z
dc.date.available2023-05-03T15:15:50Z
dc.date.issued2022-11-28
dc.description.abstractThe use of anabolic steroids affects not only professional athletes but also the general population (bodybuilders, gym clients, and adolescents). In the first case, its use is prohibited and sanctioned by the World Anti-Doping Agency and Olympic committees. For the other users, it is difficult to establish its prevalence since many obtain the products via the Internet. The reasons for its use are varied and different forms of use and other types of users have been described. Among the side effects of steroid use, hypogonadism is the most frequent cause for endocrinological consultation. After a general introduction to doping, this review describes the historical background of anabolic-androgenic steroids, their classification, forms of use, phy-siological effects, adverse effects on different organs and systems, treatment of hypogonadism, as well as detection methods. (C) 2022 The Authors. Published by Elsevier Espana, S.L.U.
dc.identifier.doi10.1016/j.rce.2022.09.003
dc.identifier.essn1578-1860
dc.identifier.issn0014-2565
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.rce.2022.09.003
dc.identifier.urihttp://hdl.handle.net/10668/22486
dc.identifier.wosID904645400007
dc.issue.number10
dc.journal.titleRevista clinica espanola
dc.journal.titleabbreviationRev. clin. esp.
dc.language.isoes
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number612-620
dc.publisherEdiciones doyma s a
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAnabolic steroids
dc.subjectAndrogen
dc.subjectDoping
dc.subjectAthletes
dc.subjectGym
dc.subjectTestosterone
dc.subjectAbuse
dc.subjectPrevalence
dc.subjectUsers
dc.subjectConsequences
dc.subjectPharmacology
dc.subjectTherapy
dc.titleDoping and sports endocrinology: anabolic-androgenic steroids
dc.typereview
dc.type.hasVersionVoR
dc.volume.number222
dc.wostypeReview
dspace.entity.typePublication

Files